Assistant Professor Lindsey Simon was featured in The Wall Street Journal regarding her thoughts on potential challenges that opioid manufacturer Insys Therapeutics may face if it files for bankruptcy without finalizing a Department of Justice settlement. The article titled "Opioid Trouble Weighs on Insys as Short Sellers Cash In" was written by Peg Brickley and Andrew Scurria and published 5/13/19.